Epigenetic mechanisms such as histone-acetylation have been implicated with learning and memory and are believed to contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). Histone-deacetylase (HDAC) inhibitors were shown to exhibit neuroprotective and neurodegenerative properties in AD animal models, and targeting HDACs appears to be a promising therapeutic strategy for brain diseases. The role of the distinct HDAC proteins in the adult brain is, however, not well understood and so far only pan-HDAC inhibitors have been tested in preclinical settings. Understanding the role of individual HDACs in cognition and AD pathogenesis is therefore vital to develop more selective HDAC inhibitors for the treatment of AD. In this study we investigated the role of HDAC5 in memory function and AD pathogenesis. We show that loss of HDAC5 impairs memory function but has little impact on pathogenesis in a mouse model for amyloid pathology. Our data reveals a novel role of HDAC5 in memory consolidation and shows that future approaches to develop more selective HDAC inhibitors for the treatment of AD should avoid targeting HDAC5.

Loss of HDAC5 impairs memory function : implications for Alzheimer's disease / R.C. Agis-Balboa, Z. Pavelka, C. Kerimoglua, A. Fischer. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 33:1(2013), pp. 35-44. [10.3233/JAD-2012-121009]

Loss of HDAC5 impairs memory function : implications for Alzheimer's disease

Z. Pavelka
Secondo
;
2013

Abstract

Epigenetic mechanisms such as histone-acetylation have been implicated with learning and memory and are believed to contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). Histone-deacetylase (HDAC) inhibitors were shown to exhibit neuroprotective and neurodegenerative properties in AD animal models, and targeting HDACs appears to be a promising therapeutic strategy for brain diseases. The role of the distinct HDAC proteins in the adult brain is, however, not well understood and so far only pan-HDAC inhibitors have been tested in preclinical settings. Understanding the role of individual HDACs in cognition and AD pathogenesis is therefore vital to develop more selective HDAC inhibitors for the treatment of AD. In this study we investigated the role of HDAC5 in memory function and AD pathogenesis. We show that loss of HDAC5 impairs memory function but has little impact on pathogenesis in a mouse model for amyloid pathology. Our data reveals a novel role of HDAC5 in memory consolidation and shows that future approaches to develop more selective HDAC inhibitors for the treatment of AD should avoid targeting HDAC5.
Alzheimer's disease; amyloid pathology; epigenetics; HDAC inhibitors; histone deacetylases; learning and memory; neurodegenerative diseases
Settore M-FIL/02 - Logica e Filosofia della Scienza
2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
JAD.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 817.3 kB
Formato Adobe PDF
817.3 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/223089
Citazioni
  • ???jsp.display-item.citation.pmc??? 42
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 89
social impact